Antimicrobial Activity of Chimera Peptides Composed of Human Neutrophil Peptide 1 (HNP-1) Truncated Analogues and Bovine Lactoferrampin

被引:7
|
作者
Ptaszynska, Natalia [1 ]
Gucwa, Katarzyna [1 ,2 ]
Legowska, Anna [1 ]
Debowski, Dawid [1 ]
Gitlin-Domagalska, Agata [1 ]
Lica, Jan [2 ]
Heldt, Mateusz [2 ]
Martynow, Dorota [2 ]
Olszewski, Mateusz [2 ]
Milewski, Slawomir [2 ]
Ng, Tzi Bun [3 ]
Rolka, Krzysztof [1 ]
机构
[1] Univ Gdansk, Dept Mol Biochem, Fac Chem, Wita Stwosza 63, PL-80308 Gdansk, Poland
[2] Gdansk Univ Technol, Dept Pharmaceut Technol & Biochem, Fac Chem, Narutowicza 11-12, PL-80233 Gdansk, Poland
[3] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Shatin, Hong Kong, Peoples R China
关键词
BACTERIAL-RESISTANCE; IN-VIVO; CELLS; MECHANISMS; IMMUNITY;
D O I
10.1021/acs.bioconjchem.8b00440
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Three chimera peptides composed of bovine lactoferrampin and the analogue of truncated human neutrophil peptide 1 were synthesized by the solid-phase method. In two compounds peptide chains were connected via isopeptide bond, whereas in the third one disulfide bridge served as a linker. All three chimeras displayed significantly higher antimicrobial activity than the constituent peptides as well as their equimolar mixtures. The one with a disulfide bridge displayed selectivity toward Gram-positive bacteria and was able to penetrate bacterial cells. The chimeric peptides demonstrated low in vitro mammalian cytotoxicity, especially against benign cells. The significance of linker type was also reflected in the secondary structure and proteolytic stability of studied compounds. Presented results proved that such chimeras are good lead structures for designing antimicrobial drugs.
引用
收藏
页码:3060 / 3071
页数:12
相关论文
共 50 条
  • [1] Antimicrobial activities of chimera peptides composed of human neutrophil peptide 1 (HNP-1) truncated analogues and bovine lactoferrampin
    Ptaszynska, Natalia
    Gucwa, Katarzyna
    Legowska, Anna
    Debowski, Dawid
    Gitlin-Domagalska, Agata
    Lica, Jan
    Heldt, Mateusz
    Martynow, Dorota
    Olszewski, Mateusz
    Milewski, Slawomir
    Rolka, Krzysztof
    [J]. JOURNAL OF PEPTIDE SCIENCE, 2018, 24 : S164 - S164
  • [2] Antimicrobial activity of truncated α-defensin (human neutrophil peptide (HNP)-1) analogues without disulphide bridges
    Lundy, Fionnuala T.
    Nelson, John
    Lockhart, Derek
    Greer, Brett
    Harriott, Pat
    Marley, John J.
    [J]. MOLECULAR IMMUNOLOGY, 2008, 45 (01) : 190 - 193
  • [3] Computational evaluation of modified peptides from human neutrophil peptide 1 (HNP-1)
    Moazzezy, Neda
    Rismani, Elham
    Rezaei, Maryam
    Karam, Mohammad Reza Asadi
    Rafati, Sima
    Bouzari, Saeid
    Oloomi, Mana
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (03): : 1163 - 1171
  • [4] Identification of human neutrophil α-defensin 1 (HNP-1) as major antimicrobial peptide of healthy skin keratinocytes
    Harder, J
    Meyer-Hoffert, U
    Bartels, J
    Sticherling, M
    Christophers, E
    Schroder, JM
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) : 447 - 447
  • [5] Human Neutrophil Peptide-1 (HNP-1): A New AntiLeishmanial Drug Candidate
    Dabirian, Sara
    Taslimi, Yasaman
    Zahedifard, Farnaz
    Gholami, Elham
    Doustdari, Fatemeh
    Motamedirad, Mahdieh
    Khatami, Shohreh
    Azadmanesh, Kayhan
    Nylen, Susanne
    Rafati, Sima
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2013, 7 (10):
  • [6] Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines
    Varkey, J
    Nagaraj, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) : 4561 - 4566
  • [7] THE ANIONIC PROPIECE OF THE HUMAN DEFENSIN HNP-1 IS AN ACTIVATION PEPTIDE
    VALORE, E
    MARTIN, E
    GANZ, T
    [J]. CLINICAL RESEARCH, 1994, 42 (02): : A151 - A151
  • [8] Salivary histatin 5 and human neutrophil peptide-1 (HNP-1) share a common candidacidal pathway.
    Araujo, MWB
    Koshlukova, S
    Patel, R
    Edgerton, M
    [J]. JOURNAL OF DENTAL RESEARCH, 2000, 79 : 174 - 174
  • [9] Effect of antimicrobial peptides HNP-1 and hBD-1 on Staphylococcus aureus strains in vitro and in vivo
    Bolatchiev, Albert
    Baturin, Vladimir
    Bazikov, Igor
    Maltsev, Alexander
    Kunitsina, Elena
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2020, 34 (01) : 102 - 108
  • [10] The defensin-lipid interaction: Insights on the binding states of the human antimicrobial peptide HNP-1 to model bacterial membranes
    Bonucci, Alessio
    Balducci, Enrico
    Pistolesi, Sara
    Pogni, Rebecca
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2013, 1828 (02): : 758 - 764